StockData
Cingulate Inc. logo

Cingulate Inc. (CING) stock

CINGNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CINGW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$4.64+0.08 (+1.75%)

Close on Nov 11, 2026Market cap $67.47MP/E –Yield –

Cingulate enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Cingulate's enterprise value was $36.07M on Nov 11, 2026, against $16.18M a year earlier. Over the last 5 years it ranged from $1.02M to $269.97M, with a median of $38.42M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$36.07M+82.0%
2025Dec 31, 2025$19.82M+299.0%
2024Dec 31, 2024$4.97M-94.0%
2023Dec 29, 2023$83.48M-38.4%
2022Dec 30, 2022$135.62M–

More Cingulate figures

See a number that looks wrong?